Related Experiment Video
Updated: Aug 21, 2026

Visualizing Membrane Ruffle Formation using Scanning Electron Microscopy
Published on: May 27, 2021
Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density
Howard S Kruth1, Nancy L Jones, Wei Huang
1Section of Experimental Atherosclerosis, NHLBI, National Institutes of Health, Bethesda, Maryland 20892-1422, USA. kruthh@nhlbi.nih.gov
Abstract:
Previously, we reported that fluid-phase endocytosis of native LDL by PMA-activated human monocytederived macrophages converted these macrophages into cholesterol-enriched foam cells (Kruth, H. S., Huang, W., Ishii, I., and Zhang, W. Y. (2002) J. Biol. Chem. 277, 34573-34580). Uptake of fluid by cells can occur either by micropinocytosis within vesicles (<0.1 microm diameter) or by macropinocytosis within vacuoles ( approximately 0.5-5.0 microm) named macropinosomes. The current investigation has identified macropinocytosis as the pathway for fluid-phase LDL endocytosis and determined signaling and cytoskeletal components involved in this LDL endocytosis. The phosphatidylinositol 3-kinase inhibitor, LY294002, which inhibits macropinocytosis but does not inhibit micropinocytosis, completely blocked PMA-activated macrophage uptake of fluid and LDL. Also, nystatin and filipin, inhibitors of micropinocytosis from lipid-raft plasma membrane domains, both failed to inhibit PMA-stimulated macrophage cholesterol accumulation. Time-lapse video phase-contrast microscopy and time-lapse digital confocal-fluorescence microscopy with fluorescent DiI-LDL showed that PMA-activated macrophages took up LDL in the fluid phase by macropinocytosis. Macropinocytosis of LDL depended on Rho GTPase signaling, actin, and microtubules. Bafilomycin A1, the vacuolar H+-ATPase inhibitor, inhibited degradation of LDL and caused accumulation of undegraded LDL within macropinosomes and multivesicular body endosomes. LDL in multivesicular body endosomes was concentrated >40-fold over its concentration in the culture medium consistent with macropinosome shrinkage by maturation into multivesicular body endosomes. Macropinocytosis of LDL taken up in the fluid phase without receptor-mediated binding of LDL is a novel endocytic pathway that generates macrophage foam cells. Macropinocytosis in macrophages and possibly other vascular cells is a new pathway to target for modulating foam cell formation in atherosclerosis.
Insights
Macropinocytosis, a fluid-phase endocytosis pathway, drives LDL uptake in macrophages, leading to cholesterol accumulation and foam cell formation. This novel pathway offers a new target for atherosclerosis treatment.
Area of Science:
- Cell Biology
- Molecular Biology
- Cardiovascular Research
Background:
- Macrophages play a key role in atherosclerosis by accumulating cholesterol.
- Fluid-phase endocytosis is a cellular uptake mechanism for fluids and particles.
- Low-density lipoprotein (LDL) uptake by macrophages contributes to foam cell formation.
Purpose of the Study:
- To identify the specific endocytic pathway responsible for fluid-phase LDL uptake in macrophages.
- To elucidate the signaling and cytoskeletal mechanisms involved in this LDL endocytosis.
- To investigate the fate of internalized LDL and its contribution to foam cell formation.
Main Methods:
- Utilized phosphatidylinositol 3-kinase inhibitor LY294002 to differentiate between macropinocytosis and micropinocytosis.
- Employed nystatin and filipin to assess the role of lipid-raft dependent endocytosis.
- Applied time-lapse microscopy (phase-contrast and confocal fluorescence) with fluorescently labeled LDL (DiI-LDL).
- Investigated the effect of vacuolar H+-ATPase inhibitor bafilomycin A1 on LDL degradation.
Main Results:
- Macropinocytosis, not micropinocytosis, was identified as the primary pathway for fluid-phase LDL uptake in PMA-activated macrophages.
- Inhibition of macropinocytosis by LY294002 completely blocked LDL uptake, while micropinocytosis inhibitors had no effect.
- Rho GTPase signaling, actin, and microtubules were essential for macropinocytosis of LDL.
- Bafilomycin A1 treatment inhibited LDL degradation and led to LDL accumulation within macropinosomes and multivesicular bodies, indicating macropinosome maturation and shrinkage.
- LDL concentration increased significantly within multivesicular body endosomes.
Conclusions:
- Macropinocytosis of LDL, independent of receptor-mediated binding, is a novel pathway for generating macrophage foam cells.
- This macropinocytosis pathway represents a new therapeutic target for modulating foam cell formation in atherosclerosis.
- The findings highlight the importance of macropinocytosis in cellular lipid metabolism and cardiovascular disease progression.
Related Concept Videos
Receptor-mediated Endocytosis
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Receptor-Mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Pinocytosis
Pinocytosis
Pinocytosis ("cellular drinking") is one of three main types of endocytosis. In...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
